Learn More
Medchemexpress LLC Zotizalkib | 2648641-36-3 | 98.0% | C21H20F3N5O3 | 10MG

Supplier: Medchemexpress LLC HY13927910MG
Zotizalkib (TPX-0131) is a potent, CNS-penetrant, orally active inhibitor of anaplastic lymphoma kinase (ALK) designed for research use. It demonstrates low-nanomolar activity against wild-type ALK and a broad spectrum of resistance mutations and has shown antitumor effects in preclinical studies.
- Potent ALK inhibition (IC50 ≈ 1.4 nM).
- CNS-penetrant, supporting brain exposure in preclinical models.
- Active against multiple ALK resistance mutations.
- High chemical purity (~98.0%).
- Chemical formula C21H20F3N5O3 and molecular weight 447.41 g/mol.
- Supplied for research use only; not for human or clinical use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.